// App-Quantinova.ai

: Prognostic and Predictive Impact of Small PNH Clones in a Large Cohort of Patients with Myelodysplastic Syndromes and Aplastic Anemia: A Single-Center Experience

Researchers

Presenter

  • Bruno Fattizzo

Principal Investigators

  • Alan Dunlop

  • Robin M. Ireland

  • Shireen Kassam

  • Dario Consonni

  • Deborah Yallop

  • Ghulam J. Mufti

  • Judith Marsh

  • Alberto Zanella

  • Wilma Barcellini

  • Austin G. Kulasekararaj

Medical Centers

  • Hematology, Fondazione IRCCS Ca Granda Ospedale Maggiore Policlinico - University of Milan,

  • King's College Hosptial NHS Foundation Trust, London, United Kingdom

  • Department of Urology, King's College Hospital NHS Foundation Trust, London, United Kingdom

  • Epidemiology, Fondazione IRCCS Ospedale Maggiore Policlinico di Milano, Milan, Italy, Milano, Italy

  • Department of Haematological Medicine, King's College London, London, United Kingdom

  • Department of Haematological Medicine, King's College London, London, United Kingdom

  • Onco-Hematology Unit, IRCCS C- Granda Ospedale Maggiore Policlinico of Milan, Italy, Milan, Italy

  • Division of Pathology, Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Milan, Italy

  • Department of Haematological Medicine,King’s College Hospital, NIHR/Wellcome King’s Clinical Research Facility,London,United Kingdom

Locations

  • Italy

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Blood/haematological Diseases

Disease

  • Myelodysplastic Syndrome

  • Aplastic anemia

  • Anemia

Biomarkers

  • Lactate dehydrogenase

  • Tyrosine 3-Monooxygenase/Tryptophan 5-Monooxygenase Activation Protein Epsilon

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Cohort

  • Single Center

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved